Records containing: Hepatocellular Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-19Phase 1, Single-site, Single-arm, Clinical Imaging, and Blood-based Biomarker Trial Utilizing 18F-FSPG PET to Guide Therapy in Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2026-02-18The Efficacy and Safety of Adjuvant TACE in Radical Surgery for Hepatocellular Carcinoma With High-risk Recurrence Factors: A Phase III Randomized Controlled Clinical Study
-
CLINICAL_TRIALS study record update · 2026-02-18Phase I Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment
-
CLINICAL_TRIALS study record update · 2026-02-18AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2026-02-17Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-17A Phase II, Single-arm, Open-label Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC
-
CLINICAL_TRIALS study record update · 2026-02-17A Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients With High Risks of Recurrence
-
CLINICAL_TRIALS study record update · 2026-02-12The Merits of Implementing microRNAs for Diagnosing Hepatocellular Carcinoma Among Hepatitis C Patients
-
CLINICAL_TRIALS study record update · 2026-02-10Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2026-02-09Impact of Immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors: A Randomized Controlled Phase II Trial
-
CLINICAL_TRIALS study record update · 2026-02-06Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA: a Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2026-02-05PET Biodistribution Study of 68Ga-FAPI-46 in Patients With Different Malignancies: An Exploratory Biodistribution Study With Histopathology Validation
-
CLINICAL_TRIALS study record update · 2026-02-05A Phase 1/1b First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC026 in Participants With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-04Project OASIS: Optimizing Approaches to Select Implementation Strategies
-
CLINICAL_TRIALS study record update · 2026-02-04Gender-Specific Prediction Models for Hepatocellular Carcinoma Metastasis: A Machine Learning-Based Retrospective Cohort Study
-
CLINICAL_TRIALS study record update · 2026-02-03An Integrated Phase II/III Randomized Study Comparing Durvalumab and Tremelimumab +/- Hepatic ArteriaL Infusion Chemotherapy With GEMOX in Hepatocellular Carcinoma With High Tumor burdEn
-
CLINICAL_TRIALS study record update · 2026-02-02A Feasibility Study to Evaluate the Combination of Electromagnetic Tracking and Optical Imaging With Indocyanine Green (ICG) for Hepatic Biopsies
-
CLINICAL_TRIALS study record update · 2026-01-30Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
-
CLINICAL_TRIALS study record update · 2026-01-30A Phase III, Open-Label, Randomized Study of On-Demand TACE Combined With Atezolizumab Plus Bevacizumab (Atezo/Bev) or On-Demand TACE Alone in Patients With Untreated Heaptocellular Carcionma
-
CLINICAL_TRIALS study record update · 2026-01-29A Pilot Trial of Transarterial Chemoembolization With or Without Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation
-
CLINICAL_TRIALS study record update · 2026-01-29Lenvatinib in Neo-adjuvant and Adjuvant Therapy for Poor-prognosis BCLC A HepatoCellular Carcinoma Treated by Percutaneous Ablation Procedure in a Curative Intent: Multicentre Pilot Therapeutic Trial
-
CLINICAL_TRIALS study record update · 2026-01-28A Phase I Study of a p53MVA Vaccine in Combination With Pembrolizumab
-
CLINICAL_TRIALS study record update · 2026-01-28Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
-
CLINICAL_TRIALS study record update · 2026-01-26A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2026-01-26MR 7700 Multinuclear Application Clinical Study